Based in Spring Branch, Texas, Callan JMB Inc. operates through its subsidiary Coldchain Technology Services, LLC, providing thermal management and logistics solutions specifically designed for the life sciences industry. The company specializes in frozen shipping infrastructure and services for temperature-sensitive biological materials, including cell therapies, vaccines, biopharmaceuticals, diagnostic samples, reproductive materials (semen, eggs, embryos), and organs. The company also manages cold chain logistics for personalized medicine applications and infectious substances requiring strict temperature control during transport and storage.
Beyond core shipping logistics, Callan JMB offers complementary service lines including emergency preparedness management, advanced monitoring technology for temperature-sensitive shipments, and technical support services. The company also handles packaging solutions for perishable non-pharmaceutical commodities. These services address the growing infrastructure needs of life sciences companies and healthcare organizations requiring reliable cold chain management and compliance with regulatory standards for sensitive biological materials.
The company operates with a small workforce of 26 full-time employees and maintains limited geographic scope relative to larger integrated logistics providers. Founded in 2006, Callan JMB remains privately held in operational terms while listed on Nasdaq, positioning itself as a specialized provider within the broader life sciences logistics market.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.87 | $-0.87 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-28 | 0001641172-25-001249 | SEC ↗ |